We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Parkinson's disease (PD) is one of the most frequent progressive neurodegenerative diseases in the elderly. This chapter reviews the recent developments in epidemiologic research of PD. It discusses the risk factors, diagnosis, disease frequency, prognosis, intervention, and implications for clinical practice. Age is the most important risk factor for PD. Smoking is one of the determinants of PD that has been studied most frequently. For the diagnosis of PD, the postmortem neuropathologic examination of the brain is generally considered to be the gold standard. For the clinical diagnosis of PD, the generally accepted prerequisite is assessment of the presence of Parkinsonism, based on a combination of four typical clinical features, referred to as cardinal signs, that is, resting tremor, bradykinesia, rigidity, and impaired postural reflexes. The rate of deterioration of nigral cells is probably most prominent and curvilinear in the preclinical or very early phase of Parkinson's disease.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.